title: Commentary: Despite reports of catastrophic complications, why recombinant human bone morphogenetic protein-2 should be available for use in anterior cervical spine surgery.
authors.affiliation: Department of Orthopaedic Surgery, Washington University Medical Center, 660 S. Euclid Ave., St. Louis, MO 63110, USA.
authors.forename: K Daniel
authors.initials: KD
authors.lastname: Riew
authors.forename: Eugene J
authors.initials: EJ
authors.lastname: Carragee
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D055396:Bone Morphogenetic Protein 2 / Q000009:adverse effects*; D016208:Databases, Factual / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011994:Recombinant Proteins / Q000009:adverse effects; D016212:Transforming Growth Factor beta / Q000009:adverse effects*
chemical_list: D055396:Bone Morphogenetic Protein 2; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; C499469:recombinant human bone morphogenetic protein-2